Business development Belgium 2026 – Biotechnology
Take advantage of the opportunity to develop new business opportunities in one of Europe's leading biotechnology locations. As part of the market development program for SMEs of the Federal Ministry for Economic Affairs and Energy (BMWE), the following event will take place from [date] to [date]. 07. to 10. December 2026 a business development trip to Belgium took place.
Belgium is one of the most important life sciences markets in Europe and offers excellent growth prospects for companies in the fields of biotechnology, biopharmaceuticals, laboratory and analytical solutions, automation and digitalization of laboratory and production processes.
Your benefits at a glance
- Individually organized B2B meetings with potential business partners
- Company presentation to a Belgian professional audience
- Networking with decision-makers, clusters and research institutions
- Visits to companies and institutes, including renowned players in the Belgian biotech industry.
- Comprehensive market information through webinars, country briefings, and on-site expert exchange.
target audience
The trip is aimed particularly at German SMEs from the following sectors:
- Biotechnology and biopharmaceuticals
- Laboratory and analytical technology
- automation and robotics
- Laboratory IT, digitization and data management
- Cleanroom and GMP solutions
- Research, diagnostics and life sciences
Why Belgium?
With leading research institutions, strong biotech clusters, and a high concentration of innovative companies, Belgium offers ideal conditions for international collaborations and market entry into the Benelux region. Solutions for laboratory automation, quality management, digital laboratory processes, and modern analytical and production technologies are in particularly high demand.
Application deadline: July 31, 2026
The number of participants is limited to a maximum of 12 companies.
Date:
December 7, 2026 -
10 December 2026
Organizer:
PSPs Business Abroad and GHA
Documents:
